A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

Vici, Patrizia; Colucci, Giuseppe; Giotta, Francesco; Sergi, Domenico; Filippelli, Gianfranco; Perri, Pasquale; Botti, Claudio; Vizza, Enrico; Carpino, Armando; Pizzuti, Laura; Latorre, Agnese; Giannarelli, Diana; Lopez, Massimo; Di Lauro, Luigi

doi:10.1186/1756-9966-30-39

Journal of Experimental & Clinical Cancer Research

Article metrics
Last updated: Sat, 18 May 2024 11:44:16 Z

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

Access & Citations

6453

Article Accesses
21

Web of Science
16

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com